Amplia Therapeutics Limited (ASX:ATX)
Australia · Delayed Price · Currency is AUD 0.1200
-0.0050 (-4.00%)
At close: Mar 11, 2026
Amplia Therapeutics Market Cap
Amplia Therapeutics has a market cap or net worth of 64.13 million as of March 11, 2026. Its market cap has increased by 101.60% in one year.
Market Cap
64.13M
Enterprise Value
35.36M
Revenue
5.01M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.12
Market Cap Chart
Since December 23, 2013, Amplia Therapeutics's market cap has increased from 34.50M to 64.13M, an increase of 85.92%. That is a compound annual growth rate of 5.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 64.13M | -16.67% |
| Dec 31, 2025 | 76.96M | 122.90% |
| Dec 31, 2024 | 34.53M | 122.47% |
| Dec 28, 2023 | 15.52M | - |
| Dec 29, 2022 | 15.52M | -51.48% |
| Dec 31, 2021 | 31.99M | 24.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LTR Pharma | 81.80M |
| Cynata Therapeutics | 80.73M |
| Alterity Therapeutics | 76.13M |
| Imugene | 75.56M |
| Radiopharm Theranostics | 74.43M |
| Prescient Therapeutics | 63.09M |
| Neurizon Therapeutics | 57.29M |
| Proteomics International Laboratories | 53.68M |